Follow the latest in biotechnology, gene therapy developments, and life sciences research. From CRISPR advances to clinical breakthroughs.
Curated AI briefing - Updates with new content
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12C mutation and whose disease progressed after prior therapies, according to results presented at the American Association for...
Paterna says it grew human sperm in a lab and used them to make embryos; experts say peer review, genetic tests and regulation will take years.
MeiraGTx priced a $100M offering after reacquiring bota‐vec from Johnson & Johnson to fund regulatory filings and potential launches.
UGC Chairman Professor Dr Mamun Ahmed said biotechnology curricula are still overly theoretical and not aligned with industry needs.
An improved stem cell method produces functional insulin cells that reverse diabetes in mice. Scientists at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have created a more reliable way to generate insulin-producing cells from human stem cells. Their findings, published in Stem Cell Reports, show that these lab-grown...
Determining the ages of hydrothermal explosions in Yellowstone is difficult because traditional dating methods often don’t work on those deposits. But an emerging application of a technique called luminescence dating literally sheds new light on this important problem.
Researchers teach AI to spot cancer risk by squeezing individual breast cells Technology Org Headshot of researchers (IMAGE) EurekAlert! AI Learns to Predict Breast Cancer Risk from How Single Cells Respond to Pressure Genetic Engineering and Biotechnology News AI squeezes individual breast cells to learn how to spot cancer risk Medical Xpress...
Space-grown heart tissue could uncover failure pathways and improve cardiac repair Medical Xpress Biotech Research on Station Informing Advanced Cancer and Heart Treatments NASA (.gov) DNA Research on Station Promoting Cancer Therapies, Radiation Repair NASA (.gov)
The FDA has made a historic decision by approving Otarmeni, the first gene therapy aimed at treating genetic hearing loss. Developed by Regeneron Pharmaceuticals, this innovative treatment targets the OTOF gene, which is crucial for sound processing. With plans to offer the therapy free of charge to eligible patients, this breakthrough could...
The Bills moved back in 2024 before selecting Keon Coleman in the second round.
AI Learns to Predict Breast Cancer Risk from How Single Cells Respond to Pressure Genetic Engineering and Biotechnology News Headshot of researchers (IMAGE) EurekAlert! AI squeezes individual breast cells to learn how to spot cancer risk Medical Xpress City of Hope and UC Berkeley Researchers Teach AI to Spot Cancer Risk by Squeezing Individual...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming...
NEWYou can now listen to Fox News articles! A new therapy for genetic hearing loss has just been approved by [...]
As China pours billions into biotech, a new analysis argues U.S. leadership will hinge on state-level tax credits, training programs and public-private partnerships.
The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both pediatric and adult patients after positive results.
TUCSON, AZ / ACCESS Newswire / April 23, 2026 / WEED Inc. (OTCQB:BUDZ) ("BUDZ" or the "Company"), a cannabis bioresearch and genetics-focused public company, today issued a strategic corporate update following the U.S. Department of Justice and Drug Enforcement Administration announcement placing FDA-approved marijuana products and marijuana...
The Department of Justice's Office of the Inspector General announced Thursday that it would do an audit of the release of the Epstein files.
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that it will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on Wednesday, May 6 to provide a corporate update and discuss its financial results for the first quarter ended March 31, 2026. The conference call may be accessed on the Events &...
The Oregon Ducks will see some of their former players take one more step towards their dream in the first round of the NFL Draft on Thursday.
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Excessive Daytime Sleepiness pipeline constitutes 10+ key companies continuously working towards developing 12+ Excessive Daytime Sleepiness treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration,
Ayatollah Mojtaba Khamenei Surrounded By 24/7 Medical Team In Hideout As Generals Run Iran: NYT The NY Times in a new deep dive of what governing structures now look like inside Iran says what's already long been obvious to many in the wake of longtime Ayatollah Ali Khamenei's death: "When Ayatollah Ali Khamenei ruled Iran as the supreme...
Market Summary As per Data Bridge Market Research analysis, the Regenerative Medicine Market was estimated at USD 42.48 billion in 2025. The market is expected to grow from USD 50.90 billion in 2026 to USD 180.15 billion in 2033, at a
[»] Jump to Summary... A fresh push to connect Nigerian ideas with real-world business value is gaining momentum as the Federal Ministry of Innovation, Science and Technology (FMIST), led by Dr. Kingsley Tochukwu Udeh, SAN, announces a major collaboration with the Kano State Government and other partners ahead of the launch of the Energise...
More than two in five U.S. adults has prediabetes, a condition marked by higher-than-normal blood sugar levels that often leads to type 2 diabetes.
AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- In an era where marketing teams are under increasing pressure to prove real business impact with volume-driven metrics and inconsistent lead quality, Vereigen Media, a leading U.S.-based B2B demand generation company, today announced the launch of its Revenue-First Demand Generation Programs....
/CNW/ - The Honourable Sean Fraser, Minister of Justice and Attorney General of Canada and Minister responsible for the Atlantic Canada Opportunities Agency,...
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals Inc.’s DB-OTO, an AAV-mediated gene therapy. Branded Otarmeni (lunsotogene parvec), it is cleared specifically for hearing loss caused by variants in the otoferlin gene.
The radiosurgery and radiotherapy robotics sector is poised for significant expansion as technological advances and increasing healthcare demands drive the market forward. With innovations enhancing treatment precision and personalized care, the industry is set to grow substantially over the next
Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how advancing drug pipelines are reshaping biotech valuations, as scientific progress is increasingly recognized as a measurable financial asset under evolving accounting frameworks. The piece highlights Oncotelic’s position at the intersection of...
Create your own AI-powered briefing on any topic — delivered automatically.
You might also enjoy these briefings
Track artificial intelligence research news, breakthrough announcements, and...
Daily briefing on AI breakthroughs in 2026. Covers latest advancements,...
Follow healthtech innovations, telemedicine developments, and digital health...
Track FDA drug approvals, clinical trial results, and pharmaceutical...
Enjoyed this briefing? Get it delivered to your inbox!
Create Free Account
